Superbugs threaten lives and may cost $2 trillion a year by 2050: Report

Bacteria with antimicrobial resistance can cause millions of deaths worldwide and cost GDP losses in the global economy. According to a report, these superbugs could cost the global economy nearly $2 trillion annually by 2050.

The study named ‘Forecasting the Fallout from AMR: Economic Impacts of Antimicrobial Resistance in Humans’ highlighted that the economies hardest hit will be the US, UK and EU economies.

In this scenario, funding cuts in research and development related to superbugs can have dire consequences.

On Thursday, the UK government announced it would cut funding for the Fleming Fund, which supports the fight against AMR in low and middle-income countries. 

Meanwhile, theTrump administration confirmed $9 billion in cuts to its foreign aid spending, and several European nations have also scaled back their overseas aid commitments